Description |
angiotensinogen |
renin |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Remikiren
- Minoxidil
- N,N-dimethylformamide
- 1-Hydroxy-3-Methylbutane
- 3-Phenyl-1,2-Propandiol
- 2-Methyl-3-(2-Aminothiazolo)Propanal
- Enalkiren
- 2-Cyclopropylmethylenepropanal
- 1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine
- N-Methyl-N-(Methylbenzyl)Formamide
- 1-Hydroxy-2-Amino-3-Cyclohexylpropane
- SPP1148
- N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE
- 6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE
- N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE
- (2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE
- 6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE
- 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE
- 6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine
- Aliskiren
|
Diseases |
|
|
GWAS |
- Blood protein levels ( 30072576)
- Coronary artery disease ( 29212778)
- Diastolic blood pressure ( 27841878 28739976 27618452)
- Diastolic blood pressure (cigarette smoking interaction) ( 29455858)
- Diastolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- Mean arterial pressure ( 27618448)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Pancreatic ductal adenocarcinoma ( 30541042)
- Response to cognitive-behavioural therapy in anxiety disorder ( 31123309)
- Systolic blood pressure ( 27841878 27618452 30578418)
- Systolic blood pressure (cigarette smoking interaction) ( 29455858)
- Systolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
|
- Blood protein levels ( 29875488)
- Blood protein levels in cardiovascular risk ( 28369058)
- Response to cognitive-behavioural therapy in anxiety disorder ( 31123309)
|
Interacting Genes |
22 interacting genes:
ACE2
AGTR1
AGTR2
ATP6AP2
CMA1
CTSG
DNPEP
ECE1
ENPEP
EWSR1
GRB2
GSDMB
ITSN2
KNG1
MAS1
MEP1A
MME
PRCP
PREP
PRG2
REN
TP53
|
9 interacting genes:
AGT
ATP6AP2
CCDC24
CTSB
KCTD15
M6PR
PCSK1
PCSK5
RENBP
|
Entrez ID |
183 |
5972 |
HPRD ID |
00106 |
01564 |
Ensembl ID |
ENSG00000135744
|
ENSG00000143839
|
Uniprot IDs |
B0ZBE2
B2R5S1
P01019
|
P00797
|
PDB IDs |
1N9U
1N9V
2JP8
2WXW
2X0B
3CK0
3WOO
3WOR
4AA1
4APH
4FYS
5E2Q
5M3X
5M3Y
5XJM
6I3F
6I3I
|
1BBS
1BIL
1BIM
1HRN
1RNE
2BKS
2BKT
2FS4
2G1N
2G1O
2G1R
2G1S
2G1Y
2G20
2G21
2G22
2G24
2G26
2G27
2I4Q
2IKO
2IKU
2IL2
2REN
2V0Z
2V10
2V11
2V12
2V13
2V16
2X0B
3D91
3G6Z
3G70
3G72
3GW5
3K1W
3KM4
3O9L
3OAD
3OAG
3OOT
3OQF
3OQK
3OWN
3Q3T
3Q4B
3Q5H
3SFC
3VCM
3VSW
3VSX
3VUC
3VYD
3VYE
3VYF
4AMT
4GJ5
4GJ6
4GJ7
4GJ8
4GJ9
4GJA
4GJB
4GJC
4GJD
4PYV
4Q1N
4RYC
4RYG
4RZ1
4S1G
4XX3
4XX4
5KOQ
5KOS
5KOT
5SXN
5SY2
5SY3
5SZ9
5T4S
5TMG
5TMK
5V8V
5VPM
5VRP
6I3F
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|